Global Drug Repositioning Market Growth (Status and Outlook) 2024-2030

The global Drug Repositioning market size was valued at US$ 25,700 million in 2023. With growing demand in downstream markets, driven by the need for cost-effective drug developmen

According to our publisher’s latest study, the global Drug Repositioning market size was valued at US$ 25700 million in 2023. With growing demand in downstream market, the Drug Repositioning is forecast to a readjusted size of US$ 35860 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Drug Repositioning market. Drug Repositioning are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug Repositioning. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug Repositioning market. Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication. Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%. North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent. In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases. Key Features: The report on Drug Repositioning market reflects various aspects and provide valuable insights into the industry. Market Size and Growth: The research report provide an overview of the current size and growth of the Drug Repositioning market. It may include historical data, market segmentation by Type (e.g., Generic Drugs, Clinical Trial Failed Drugs), and regional breakdowns. Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drug Repositioning market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs. Market Drivers: Growing demand for innovative treatments: The increasing need for effective and innovative treatments for various diseases and conditions is driving the demand for drug repositioning. Cost savings: Drug repositioning can reduce the cost of drug development by leveraging existing clinical data and reducing the need for additional clinical trials. Accelerated time-to-market: Repurposing existing drugs can accelerate the time-to-market for new treatments, reducing the time and cost associated with traditional drug development. Increased focus on personalized medicine: The growing trend towards personalized medicine is driving the need for targeted treatments, which can be achieved through drug repositioning. Advances in technology and data analysis: Advances in technology and data analysis are enabling the identification of new therapeutic applications for existing drugs, driving the growth of the drug repositioning market. Growing awareness of the benefits of drug repositioning: The growing awareness of the benefits of drug repositioning, including cost savings and accelerated time-to-market, is driving adoption in the pharmaceutical industry. Market Challenges: Regulatory hurdles: The regulatory environment for drug repositioning is complex and challenging, with varying requirements across different regions and countries. Lack of standardization: The lack of standardization in the drug repositioning process can lead to inconsistent results and make it difficult to replicate successful repositioning strategies. High failure rates: The high failure rates associated with drug repositioning can be discouraging for pharmaceutical companies and investors. Competition from traditional drug development: The traditional drug development process is well-established and has a long history of success, making it challenging for drug repositioning to gain traction. Limited understanding of the underlying biology: The limited understanding of the underlying biology of diseases and conditions can make it difficult to identify suitable candidates for drug repositioning. High costs: The high costs associated with drug repositioning, including the cost of clinical trials and regulatory approvals, can be a barrier to entry for smaller pharmaceutical companies. Competitive Landscape: The research report provides analysis of the competitive landscape within the Drug Repositioning market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market. Technological Developments: The research report can delve into the latest technological developments in the Drug Repositioning industry. This include advancements in Drug Repositioning technology, Drug Repositioning new entrants, Drug Repositioning new investment, and other innovations that are shaping the future of Drug Repositioning. The global drug repositioning market is growing rapidly, driven by advancements in technologies such as bioinformatics, genomics, and proteomics. These technologies are enabling the identification of new therapeutic applications for existing drugs, reducing development costs and time, and improving return on investment. Advancements in Bioinformatics Machine learning algorithms: Machine learning algorithms are being used to analyze large datasets and identify patterns that can help predict the potential of a drug for repositioning. Data integration: Integration of data from various sources, such as genomic and proteomic data, is enabling the identification of new therapeutic targets and the development of new drugs. Advancements in Genomics Next-generation sequencing: Next-generation sequencing technologies are enabling the rapid and cost-effective analysis of genomic data, which is critical for identifying new therapeutic targets and developing new drugs. Genomic editing: Genomic editing technologies, such as CRISPR/Cas9, are enabling the precise modification of genes, which can help to develop new drugs and therapies. Advancements in Proteomics Mass spectrometry: Mass spectrometry technologies are enabling the rapid and sensitive analysis of protein expression and modification, which is critical for identifying new therapeutic targets and developing new drugs. Protein-protein interaction analysis: Protein-protein interaction analysis is enabling the identification of new therapeutic targets and the development of new drugs. Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drug Repositioning market. It includes factors influencing customer ' purchasing decisions, preferences for Drug Repositioning product. Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drug Repositioning market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drug Repositioning market. The report also evaluates the effectiveness of these policies in driving market growth. Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drug Repositioning market. Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drug Repositioning industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments. Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drug Repositioning market. Recommendations: Invest in Research and Development: The global Drug Repurposing market is growing rapidly, driven by the need for new treatments and the increasing success of repurposed drugs. Investing in R&D is crucial to identify new uses for existing drugs and to develop new treatments. Collaborate with Pharmaceutical Companies: Collaborations between pharmaceutical companies, research institutions, and government agencies can accelerate the development of new treatments and reduce the risk of failure. Improve Awareness and Education: Lack of awareness and education among healthcare professionals, patients, and the general public is a significant barrier to the adoption of drug repurposing. Efforts to increase awareness and education are essential to promote the benefits and opportunities in this field. Focus on Emerging Markets: Emerging markets, such as Latin America and the Middle East & Africa, present significant opportunities for drug repurposing. These markets offer potential for repurposed drugs to address prevalent diseases and improve access to affordable treatments. Opportunities: Growing Demand for New Treatments: The global Drug Repurposing market is driven by the need for new treatments for chronic diseases such as cancer, tuberculosis, and Alzheimer’s disease. Increasing Success of Repurposed Drugs: The success of repurposed drugs, such as those used to treat hypertension and neuropathic pain, has increased confidence in the potential of drug repurposing. Advances in Technology: Advances in technologies such as bi-random walk-based algorithms and random walk-based network algorithms have improved the accuracy and efficiency of drug repurposing. Government Support: Governments are providing support for drug repurposing initiatives through funding and regulatory incentives, which is driving growth in the market. Market Segmentation: Drug Repositioning market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Segmentation by type Generic Drugs Clinical Trial Failed Drugs Segmentation by application Cardiovascular Diseases Mental Illness Cancer Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Teva Novartis Mylan Johnson & Johnson Pfizer Bausch Health GSK ChemRar Group Glenmark Fujifilm Dr. Reddy R-Pharma

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Drug Repositioning Market Size 2019-2030
  • 2.1.2 Drug Repositioning Market Size CAGR by Region 2019 VS 2023 VS 2030
  • 2.2 Drug Repositioning Segment by Type
  • 2.2.1 Generic Drugs
  • 2.2.2 Clinical Trial Failed Drugs
  • 2.3 Drug Repositioning Market Size by Type
  • 2.3.1 Drug Repositioning Market Size CAGR by Type (2019 VS 2023 VS 2030)
  • 2.3.2 Global Drug Repositioning Market Size Market Share by Type (2019-2024)
  • 2.4 Drug Repositioning Segment by Application
  • 2.4.1 Cardiovascular Diseases
  • 2.4.2 Mental Illness
  • 2.4.3 Cancer
  • 2.4.4 Others
  • 2.5 Drug Repositioning Market Size by Application
  • 2.5.1 Drug Repositioning Market Size CAGR by Application (2019 VS 2023 VS 2030)
  • 2.5.2 Global Drug Repositioning Market Size Market Share by Application (2019-2024)
  • 3 Drug Repositioning Market Size by Player
  • 3.1 Drug Repositioning Market Size Market Share by Players
  • 3.1.1 Global Drug Repositioning Revenue by Players (2019-2024)
  • 3.1.2 Global Drug Repositioning Revenue Market Share by Players (2019-2024)
  • 3.2 Global Drug Repositioning Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion
  • 4 Drug Repositioning by Regions
  • 4.1 Drug Repositioning Market Size by Regions (2019-2024)
  • 4.2 Americas Drug Repositioning Market Size Growth (2019-2024)
  • 4.3 APAC Drug Repositioning Market Size Growth (2019-2024)
  • 4.4 Europe Drug Repositioning Market Size Growth (2019-2024)
  • 4.5 Middle East & Africa Drug Repositioning Market Size Growth (2019-2024)
  • 5 Americas
  • 5.1 Americas Drug Repositioning Market Size by Country (2019-2024)
  • 5.2 Americas Drug Repositioning Market Size by Type (2019-2024)
  • 5.3 Americas Drug Repositioning Market Size by Application (2019-2024)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Drug Repositioning Market Size by Region (2019-2024)
  • 6.2 APAC Drug Repositioning Market Size by Type (2019-2024)
  • 6.3 APAC Drug Repositioning Market Size by Application (2019-2024)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 7 Europe
  • 7.1 Europe Drug Repositioning by Country (2019-2024)
  • 7.2 Europe Drug Repositioning Market Size by Type (2019-2024)
  • 7.3 Europe Drug Repositioning Market Size by Application (2019-2024)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Drug Repositioning by Region (2019-2024)
  • 8.2 Middle East & Africa Drug Repositioning Market Size by Type (2019-2024)
  • 8.3 Middle East & Africa Drug Repositioning Market Size by Application (2019-2024)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Global Drug Repositioning Market Forecast
  • 10.1 Global Drug Repositioning Forecast by Regions (2025-2030)
  • 10.1.1 Global Drug Repositioning Forecast by Regions (2025-2030)
  • 10.1.2 Americas Drug Repositioning Forecast
  • 10.1.3 APAC Drug Repositioning Forecast
  • 10.1.4 Europe Drug Repositioning Forecast
  • 10.1.5 Middle East & Africa Drug Repositioning Forecast
  • 10.2 Americas Drug Repositioning Forecast by Country (2025-2030)
  • 10.2.1 United States Drug Repositioning Market Forecast
  • 10.2.2 Canada Drug Repositioning Market Forecast
  • 10.2.3 Mexico Drug Repositioning Market Forecast
  • 10.2.4 Brazil Drug Repositioning Market Forecast
  • 10.3 APAC Drug Repositioning Forecast by Region (2025-2030)
  • 10.3.1 China Drug Repositioning Market Forecast
  • 10.3.2 Japan Drug Repositioning Market Forecast
  • 10.3.3 Korea Drug Repositioning Market Forecast
  • 10.3.4 Southeast Asia Drug Repositioning Market Forecast
  • 10.3.5 India Drug Repositioning Market Forecast
  • 10.3.6 Australia Drug Repositioning Market Forecast
  • 10.4 Europe Drug Repositioning Forecast by Country (2025-2030)
  • 10.4.1 Germany Drug Repositioning Market Forecast
  • 10.4.2 France Drug Repositioning Market Forecast
  • 10.4.3 UK Drug Repositioning Market Forecast
  • 10.4.4 Italy Drug Repositioning Market Forecast
  • 10.4.5 Russia Drug Repositioning Market Forecast
  • 10.5 Middle East & Africa Drug Repositioning Forecast by Region (2025-2030)
  • 10.5.1 Egypt Drug Repositioning Market Forecast
  • 10.5.2 South Africa Drug Repositioning Market Forecast
  • 10.5.3 Israel Drug Repositioning Market Forecast
  • 10.5.4 Turkey Drug Repositioning Market Forecast
  • 10.5.5 GCC Countries Drug Repositioning Market Forecast
  • 10.6 Global Drug Repositioning Forecast by Type (2025-2030)
  • 10.7 Global Drug Repositioning Forecast by Application (2025-2030)
  • 11 Key Players Analysis
  • 11.1 Teva
  • 11.1.1 Teva Company Information
  • 11.1.2 Teva Drug Repositioning Product Offered
  • 11.1.3 Teva Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
  • 11.1.4 Teva Main Business Overview
  • 11.1.5 Teva Latest Developments
  • 11.2 Novartis
  • 11.2.1 Novartis Company Information
  • 11.2.2 Novartis Drug Repositioning Product Offered
  • 11.2.3 Novartis Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
  • 11.2.4 Novartis Main Business Overview
  • 11.2.5 Novartis Latest Developments
  • 11.3 Mylan
  • 11.3.1 Mylan Company Information
  • 11.3.2 Mylan Drug Repositioning Product Offered
  • 11.3.3 Mylan Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
  • 11.3.4 Mylan Main Business Overview
  • 11.3.5 Mylan Latest Developments
  • 11.4 Johnson & Johnson
  • 11.4.1 Johnson & Johnson Company Information
  • 11.4.2 Johnson & Johnson Drug Repositioning Product Offered
  • 11.4.3 Johnson & Johnson Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
  • 11.4.4 Johnson & Johnson Main Business Overview
  • 11.4.5 Johnson & Johnson Latest Developments
  • 11.5 Pfizer
  • 11.5.1 Pfizer Company Information
  • 11.5.2 Pfizer Drug Repositioning Product Offered
  • 11.5.3 Pfizer Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
  • 11.5.4 Pfizer Main Business Overview
  • 11.5.5 Pfizer Latest Developments
  • 11.6 Bausch Health
  • 11.6.1 Bausch Health Company Information
  • 11.6.2 Bausch Health Drug Repositioning Product Offered
  • 11.6.3 Bausch Health Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
  • 11.6.4 Bausch Health Main Business Overview
  • 11.6.5 Bausch Health Latest Developments
  • 11.7 GSK
  • 11.7.1 GSK Company Information
  • 11.7.2 GSK Drug Repositioning Product Offered
  • 11.7.3 GSK Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
  • 11.7.4 GSK Main Business Overview
  • 11.7.5 GSK Latest Developments
  • 11.8 ChemRar Group
  • 11.8.1 ChemRar Group Company Information
  • 11.8.2 ChemRar Group Drug Repositioning Product Offered
  • 11.8.3 ChemRar Group Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
  • 11.8.4 ChemRar Group Main Business Overview
  • 11.8.5 ChemRar Group Latest Developments
  • 11.9 Glenmark
  • 11.9.1 Glenmark Company Information
  • 11.9.2 Glenmark Drug Repositioning Product Offered
  • 11.9.3 Glenmark Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
  • 11.9.4 Glenmark Main Business Overview
  • 11.9.5 Glenmark Latest Developments
  • 11.10 Fujifilm
  • 11.10.1 Fujifilm Company Information
  • 11.10.2 Fujifilm Drug Repositioning Product Offered
  • 11.10.3 Fujifilm Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
  • 11.10.4 Fujifilm Main Business Overview
  • 11.10.5 Fujifilm Latest Developments
  • 11.11 Dr. Reddy
  • 11.11.1 Dr. Reddy Company Information
  • 11.11.2 Dr. Reddy Drug Repositioning Product Offered
  • 11.11.3 Dr. Reddy Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
  • 11.11.4 Dr. Reddy Main Business Overview
  • 11.11.5 Dr. Reddy Latest Developments
  • 11.12 R-Pharma
  • 11.12.1 R-Pharma Company Information
  • 11.12.2 R-Pharma Drug Repositioning Product Offered
  • 11.12.3 R-Pharma Drug Repositioning Revenue, Gross Margin and Market Share (2019-2024)
  • 11.12.4 R-Pharma Main Business Overview
  • 11.12.5 R-Pharma Latest Developments
  • 12 Research Findings and Conclusion

Table 1. Drug Repositioning Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions) Table 2. Major Players of Generic Drugs Table 3. Major Players of Clinical Trial Failed Drugs Table 4. Drug Repositioning Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions) Table 5. Global Drug Repositioning Market Size by Type (2019-2024) & ($ Millions) Table 6. Global Drug Repositioning Market Size Market Share by Type (2019-2024) Table 7. Drug Repositioning Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions) Table 8. Global Drug Repositioning Market Size by Application (2019-2024) & ($ Millions) Table 9. Global Drug Repositioning Market Size Market Share by Application (2019-2024) Table 10. Global Drug Repositioning Revenue by Players (2019-2024) & ($ Millions) Table 11. Global Drug Repositioning Revenue Market Share by Player (2019-2024) Table 12. Drug Repositioning Key Players Head office and Products Offered Table 13. Drug Repositioning Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Drug Repositioning Market Size by Regions 2019-2024 & ($ Millions) Table 17. Global Drug Repositioning Market Size Market Share by Regions (2019-2024) Table 18. Global Drug Repositioning Revenue by Country/Region (2019-2024) & ($ millions) Table 19. Global Drug Repositioning Revenue Market Share by Country/Region (2019-2024) Table 20. Americas Drug Repositioning Market Size by Country (2019-2024) & ($ Millions) Table 21. Americas Drug Repositioning Market Size Market Share by Country (2019-2024) Table 22. Americas Drug Repositioning Market Size by Type (2019-2024) & ($ Millions) Table 23. Americas Drug Repositioning Market Size Market Share by Type (2019-2024) Table 24. Americas Drug Repositioning Market Size by Application (2019-2024) & ($ Millions) Table 25. Americas Drug Repositioning Market Size Market Share by Application (2019-2024) Table 26. APAC Drug Repositioning Market Size by Region (2019-2024) & ($ Millions) Table 27. APAC Drug Repositioning Market Size Market Share by Region (2019-2024) Table 28. APAC Drug Repositioning Market Size by Type (2019-2024) & ($ Millions) Table 29. APAC Drug Repositioning Market Size Market Share by Type (2019-2024) Table 30. APAC Drug Repositioning Market Size by Application (2019-2024) & ($ Millions) Table 31. APAC Drug Repositioning Market Size Market Share by Application (2019-2024) Table 32. Europe Drug Repositioning Market Size by Country (2019-2024) & ($ Millions) Table 33. Europe Drug Repositioning Market Size Market Share by Country (2019-2024) Table 34. Europe Drug Repositioning Market Size by Type (2019-2024) & ($ Millions) Table 35. Europe Drug Repositioning Market Size Market Share by Type (2019-2024) Table 36. Europe Drug Repositioning Market Size by Application (2019-2024) & ($ Millions) Table 37. Europe Drug Repositioning Market Size Market Share by Application (2019-2024) Table 38. Middle East & Africa Drug Repositioning Market Size by Region (2019-2024) & ($ Millions) Table 39. Middle East & Africa Drug Repositioning Market Size Market Share by Region (2019-2024) Table 40. Middle East & Africa Drug Repositioning Market Size by Type (2019-2024) & ($ Millions) Table 41. Middle East & Africa Drug Repositioning Market Size Market Share by Type (2019-2024) Table 42. Middle East & Africa Drug Repositioning Market Size by Application (2019-2024) & ($ Millions) Table 43. Middle East & Africa Drug Repositioning Market Size Market Share by Application (2019-2024) Table 44. Key Market Drivers & Growth Opportunities of Drug Repositioning Table 45. Key Market Challenges & Risks of Drug Repositioning Table 46. Key Industry Trends of Drug Repositioning Table 47. Global Drug Repositioning Market Size Forecast by Regions (2025-2030) & ($ Millions) Table 48. Global Drug Repositioning Market Size Market Share Forecast by Regions (2025-2030) Table 49. Global Drug Repositioning Market Size Forecast by Type (2025-2030) & ($ Millions) Table 50. Global Drug Repositioning Market Size Forecast by Application (2025-2030) & ($ Millions) Table 51. Teva Details, Company Type, Drug Repositioning Area Served and Its Competitors Table 52. Teva Drug Repositioning Product Offered Table 53. Teva Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 54. Teva Main Business Table 55. Teva Latest Developments Table 56. Novartis Details, Company Type, Drug Repositioning Area Served and Its Competitors Table 57. Novartis Drug Repositioning Product Offered Table 58. Novartis Main Business Table 59. Novartis Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 60. Novartis Latest Developments Table 61. Mylan Details, Company Type, Drug Repositioning Area Served and Its Competitors Table 62. Mylan Drug Repositioning Product Offered Table 63. Mylan Main Business Table 64. Mylan Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 65. Mylan Latest Developments Table 66. Johnson & Johnson Details, Company Type, Drug Repositioning Area Served and Its Competitors Table 67. Johnson & Johnson Drug Repositioning Product Offered Table 68. Johnson & Johnson Main Business Table 69. Johnson & Johnson Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 70. Johnson & Johnson Latest Developments Table 71. Pfizer Details, Company Type, Drug Repositioning Area Served and Its Competitors Table 72. Pfizer Drug Repositioning Product Offered Table 73. Pfizer Main Business Table 74. Pfizer Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 75. Pfizer Latest Developments Table 76. Bausch Health Details, Company Type, Drug Repositioning Area Served and Its Competitors Table 77. Bausch Health Drug Repositioning Product Offered Table 78. Bausch Health Main Business Table 79. Bausch Health Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 80. Bausch Health Latest Developments Table 81. GSK Details, Company Type, Drug Repositioning Area Served and Its Competitors Table 82. GSK Drug Repositioning Product Offered Table 83. GSK Main Business Table 84. GSK Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 85. GSK Latest Developments Table 86. ChemRar Group Details, Company Type, Drug Repositioning Area Served and Its Competitors Table 87. ChemRar Group Drug Repositioning Product Offered Table 88. ChemRar Group Main Business Table 89. ChemRar Group Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 90. ChemRar Group Latest Developments Table 91. Glenmark Details, Company Type, Drug Repositioning Area Served and Its Competitors Table 92. Glenmark Drug Repositioning Product Offered Table 93. Glenmark Main Business Table 94. Glenmark Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 95. Glenmark Latest Developments Table 96. Fujifilm Details, Company Type, Drug Repositioning Area Served and Its Competitors Table 97. Fujifilm Drug Repositioning Product Offered Table 98. Fujifilm Main Business Table 99. Fujifilm Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 100. Fujifilm Latest Developments Table 101. Dr. Reddy Details, Company Type, Drug Repositioning Area Served and Its Competitors Table 102. Dr. Reddy Drug Repositioning Product Offered Table 103. Dr. Reddy Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 104. Dr. Reddy Main Business Table 105. Dr. Reddy Latest Developments Table 106. R-Pharma Details, Company Type, Drug Repositioning Area Served and Its Competitors Table 107. R-Pharma Drug Repositioning Product Offered Table 108. R-Pharma Main Business Table 109. R-Pharma Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 110. R-Pharma Latest Developments

Figure 1. Drug Repositioning Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Drug Repositioning Market Size Growth Rate 2019-2030 ($ Millions) Figure 6. Drug Repositioning Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Drug Repositioning Sales Market Share by Country/Region (2023) Figure 8. Drug Repositioning Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Drug Repositioning Market Size Market Share by Type in 2023 Figure 10. Drug Repositioning in Cardiovascular Diseases Figure 11. Global Drug Repositioning Market: Cardiovascular Diseases (2019-2024) & ($ Millions) Figure 12. Drug Repositioning in Mental Illness Figure 13. Global Drug Repositioning Market: Mental Illness (2019-2024) & ($ Millions) Figure 14. Drug Repositioning in Cancer Figure 15. Global Drug Repositioning Market: Cancer (2019-2024) & ($ Millions) Figure 16. Drug Repositioning in Others Figure 17. Global Drug Repositioning Market: Others (2019-2024) & ($ Millions) Figure 18. Global Drug Repositioning Market Size Market Share by Application in 2023 Figure 19. Global Drug Repositioning Revenue Market Share by Player in 2023 Figure 20. Global Drug Repositioning Market Size Market Share by Regions (2019-2024) Figure 21. Americas Drug Repositioning Market Size 2019-2024 ($ Millions) Figure 22. APAC Drug Repositioning Market Size 2019-2024 ($ Millions) Figure 23. Europe Drug Repositioning Market Size 2019-2024 ($ Millions) Figure 24. Middle East & Africa Drug Repositioning Market Size 2019-2024 ($ Millions) Figure 25. Americas Drug Repositioning Value Market Share by Country in 2023 Figure 26. United States Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 27. Canada Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 28. Mexico Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 29. Brazil Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 30. APAC Drug Repositioning Market Size Market Share by Region in 2023 Figure 31. APAC Drug Repositioning Market Size Market Share by Type in 2023 Figure 32. APAC Drug Repositioning Market Size Market Share by Application in 2023 Figure 33. China Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 34. Japan Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 35. Korea Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 36. Southeast Asia Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 37. India Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 38. Australia Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 39. Europe Drug Repositioning Market Size Market Share by Country in 2023 Figure 40. Europe Drug Repositioning Market Size Market Share by Type (2019-2024) Figure 41. Europe Drug Repositioning Market Size Market Share by Application (2019-2024) Figure 42. Germany Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 43. France Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 44. UK Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 45. Italy Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 46. Russia Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 47. Middle East & Africa Drug Repositioning Market Size Market Share by Region (2019-2024) Figure 48. Middle East & Africa Drug Repositioning Market Size Market Share by Type (2019-2024) Figure 49. Middle East & Africa Drug Repositioning Market Size Market Share by Application (2019-2024) Figure 50. Egypt Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 51. South Africa Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 52. Israel Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 53. Turkey Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 54. GCC Country Drug Repositioning Market Size Growth 2019-2024 ($ Millions) Figure 55. Americas Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 56. APAC Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 57. Europe Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 58. Middle East & Africa Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 59. United States Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 60. Canada Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 61. Mexico Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 62. Brazil Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 63. China Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 64. Japan Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 65. Korea Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 66. Southeast Asia Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 67. India Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 68. Australia Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 69. Germany Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 70. France Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 71. UK Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 72. Italy Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 73. Russia Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 74. Spain Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 75. Egypt Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 76. South Africa Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 77. Israel Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 78. Turkey Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 79. GCC Countries Drug Repositioning Market Size 2025-2030 ($ Millions) Figure 80. Global Drug Repositioning Market Size Market Share Forecast by Type (2025-2030) Figure 81. Global Drug Repositioning Market Size Market Share Forecast by Application (2025-2030)
Logo

Global Drug Repositioning Market Growth (Status and Outlook) 2024-2030

Contact usWe are friendly and approachable, give us a call.